NCT06974539View on ClinicalTrials.gov

TULIP ReTrain Study

NANot yet recruitingINTERVENTIONAL
Enrollment

212

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

December 31, 2026

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

Multiparametric ultrasound with contrast (Sonovue and Optison)

Participants will receive 3D mpUS using both Sonovue and Optison contrast agents during a single transrectal imaging session.

Trial Locations (1)

Unknown

Amsterdam UMC, Amsterdam

Sponsors

Collaborators (1)

Angiogenesis Analytics
All Listed Sponsors
collaborator

Angiogenesis Analytics

INDUSTRY

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT06974539 - TULIP ReTrain Study | Biotech Hunter | Biotech Hunter